Larotrectinib medical insurance reimbursement price in 2024

As of2024, larotrectinib (Larotrectinib) has not been included in the scope of reimbursement by domestic medical insurance. This requires patients to purchase the drug at their own expense, and it may be relatively difficult to purchase in hospitals since it has not been available in the country for a long time. Patients are advised to consult their local hospital pharmacy for the latest purchasing information when needed.

In foreign markets, larotrectinib has two options: original drug and generic drug. Original drugs include German version, American version, European version and Hong Kong version of original drugs. Depending on the version of the original drug, the price is approximately 10,000 to 20,000 yuan, and the specific price may fluctuate.

In comparison, generic drugs are much cheaper. There are Lao and Bangladeshi versions of generic drugs, and the price is generally around two to three thousand, which is more economical and affordable than the original drugs. It is worth noting that although the ingredients of original drugs and generic drugs are basically the same, there may be minor differences due to different manufacturers and manufacturing processes.

For patients, drug selection may be affected by many factors, including affordability, medical insurance, and personal preferences. Therefore, when purchasing larotrectinib, patients are advised to weigh the pros and cons and make the most appropriate choice based on detailed consultation with their doctors and pharmacists.

To sum up, although larotrectinib has not yet been included in the scope of medical insurance reimbursement in China, patients still have multiple purchasing options. According to personal circumstances and needs, you can choose original drugs or generic drugs, as well as corresponding versions, to better meet treatment needs.